Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

approved   crawled date : 2022 - 05 - 03    save search

Sunnyside Bancorp Announces Receipt of Regulatory Approvals
Published: 2022-05-03 (Crawled : 23:00) - prnewswire.com
SNNY 4 | $20.2 twitter stocktwits trandingview |
Finance and Insurance
| | O: 4.28% H: 1.15% C: 1.15%


Shareholders approve all resolutions on the agenda of Tenaris’s Annual General Meeting
Published: 2022-05-03 (Crawled : 22:00) - globenewswire.com
TS | $37.9 1.42% -0.05% 1.3M twitter stocktwits trandingview |
Non-Energy Minerals
| | O: 1.29% H: 1.6% C: 1.3%


Phathom Pharmaceuticals Announces FDA Approval of VOQUEZNA™ TRIPLE PAK™ (vonoprazan, amoxicillin, clarithromycin) and VOQUEZNA™ DUAL PAK™ (vonoprazan, amoxicillin) for the Treatment of H. pylori Infection in Adults
Published: 2022-05-03 (Crawled : 22:00) - globenewswire.com
PHAT | $8.98 -5.27% -5.57% 590K twitter stocktwits trandingview |
Health Technology
| | O: -3.35% H: 0.0% C: -3.47%

treatment fda approval infection infections
Exelixis’ Partner Ipsen Receives European Commission Approval for CABOMETYX® (cabozantinib) for Patients with Previously Treated Radioactive Iodine-Refractory Differentiated Thyroid Cancer
Published: 2022-05-03 (Crawled : 18:00) - biospace.com/
TAK | News | $13.24 0.61% 0.0% 1.3M twitter stocktwits trandingview |
Health Technology
| | O: 0.41% H: 0.0% C: 0.0%
BMY | $48.93 1.3% 0.0% 10M twitter stocktwits trandingview |
Health Technology
| | O: 0.36% H: 0.0% C: 0.0%
EXEL | $22.51 0.09% 0.09% 2.3M twitter stocktwits trandingview |
Health Technology
| | O: 0.09% H: 1.54% C: -0.44%

cabometyx approval cancer
Suneva Medical Inc. Announces Multiple Regulatory Approvals in the U.S. and Canada
Published: 2022-05-03 (Crawled : 17:00) - biospace.com/
VHAQ | $10.81 0.0% 990 twitter stocktwits trandingview |
| | O: 0.0% H: 0.0% C: 0.0%

canada
Pliant Therapeutics Receives FDA Fast Track Designation for PLN-74809 for the Treatment of Idiopathic Pulmonary Fibrosis
Published: 2022-05-03 (Crawled : 13:20) - biospace.com/
PLRX | $12.51 2.63% 2.56% 310K twitter stocktwits trandingview |
Health Technology
| | O: 0.88% H: 2.62% C: -5.26%

pln-7480 treatment fda fibrosis designation therapeutics fast track designation
Allied Corp Announces Approval of Psychoactive (THC) Quota for the Production of Colombian THC Cannabis Flower
Published: 2022-05-03 (Crawled : 13:00) - globenewswire.com
ALID | $0.1616 -73.85% 11K twitter stocktwits trandingview |
Manufacturing
| | O: -0.14% H: 6.8% C: 5.41%

cannabis thc approval
Graphite Bio Announces U.S. FDA Fast Track Designation Granted to GPH101 for the Treatment of Sickle Cell Disease
Published: 2022-05-03 (Crawled : 12:20) - biospace.com/
GRPH 4 | $3.27 1.84% 490K twitter stocktwits trandingview |
Professional, Scientific, and T...
| | O: -1.97% H: 5.28% C: 5.03%

gph101 treatment fda designation disease granted fast track designation
Global Amniotic Membrane Markets, 2022-2027: Increasing Awareness About Amniotic Membranes (AM) Due to Gaining Approval of Many Health Commissions
Published: 2022-05-03 (Crawled : 12:00) - prnewswire.com
SYK | $325.43 -0.62% 0.0% 1.8M twitter stocktwits trandingview |
Health Technology
| | O: -2.04% H: 0.0% C: 0.0%

health approval
Sonoma Pharmaceuticals and MicroSafe Group DMCC Announce EPA Approval for Nanocyn® Hospital-Grade Disinfectant in the U.S.
Published: 2022-05-03 (Crawled : 11:00) - biospace.com/
SNOA | $0.1539 -1.72% -1.75% 170K twitter stocktwits trandingview |
Health Technology
| | O: 49.22% H: 3.27% C: -11.84%

nanocyn approval disinfectant group
Ipsen: European Commission Approves Cabometyx® as a Second-Line Treatment for People Living With Radioactive Iodine-Refractory Differentiated Thyroid Cancer
Published: 2022-05-03 (Crawled : 08:00) - biospace.com/
TAK | News | $13.24 0.61% 0.0% 1.3M twitter stocktwits trandingview |
Health Technology
| | O: 0.41% H: 0.0% C: 0.0%

cabometyx treatment cancer
Favorable Regulatory Approvals for Novel Poultry Feeds to Assist the Market Surpass US$ 225.2 Bn by 2032
Published: 2022-05-03 (Crawled : 01:00) - prnewswire.com
SPXC | $116.23 -1.22% 0.0% 340K twitter stocktwits trandingview |
Producer Manufacturing
| | O: 1.6% H: 3.13% C: 1.15%
JBT | $91.71 2.23% 0.0% 270K twitter stocktwits trandingview |
Producer Manufacturing
| | O: 0.55% H: 1.81% C: 1.41%

market
Gainers vs Losers
67% 33%

Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M twitter stocktwits trandingview |
Finance

EGOX | $0.0515 43.06% 30.1% 330M twitter stocktwits trandingview |

OLB 4 | $0.33 -14.95% 25.53% 840K twitter stocktwits trandingview |
Technology Services

NVFY | $2.77 31.28% 23.83% 33M twitter stocktwits trandingview |
Consumer Durables

ZCMD | $1.87 28.97% 22.46% 31M twitter stocktwits trandingview |
Commercial Services

RCON | $0.1112 13.01% 21.28% 1.7M twitter stocktwits trandingview |
Distribution Services

INSG | $3.03 25.21% 20.13% 330K twitter stocktwits trandingview |
Electronic Technology

GCTK | $0.8191 22.25% 18.2% 190K twitter stocktwits trandingview |
Manufacturing

WLGS | $0.59 18.0% 17.9% 2.3M twitter stocktwits trandingview |

ASNS | $0.828 21.75% 17.86% 18K twitter stocktwits trandingview |


Your saved searches
Save your searches and get alerts when important news are released.